My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Sanofi - American Depositary Shares (NQ:SNY)

51.78 -0.36 (-0.69%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 17, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Sanofi - American Depositary Shares

< Previous 1 2

...

15 16 17 18 19 20 21 22 23

...

39 40 Next >

Multi-Billion Dollar Treatment Market For Lung Infection That Causes Over 200,000 Hospitalizations Annually With Elderly, Young At Most Risk Has Game-Changing New Entrant ↗

October 02, 2023

Read the latest report on NanoViricides here

Via Benzinga

Stock Split Watch: Is Regeneron Pharmaceuticals Next? ↗

September 30, 2023

If the biotech does split its stock, it will be a first for the company.

Via The Motley Fool

Dianthus' Monoclonal Antibody On Promising Pathway To Gaining The Upper Hand - Analyst ↗

September 28, 2023

Raymond James initiated coverage on Dianthus Therapeutics Inc (NASDAQ: DNTH), a recent reverse merger with the old Magenta Therapeutics.

Via Benzinga

Apple Defends Its $19B Google Search Deal, Hollywood's Writers Secure Credit For AI Training, China's Ambitious Chip Fund Faces Headwinds: Today's Top Stories ↗

September 27, 2023

Benzinga Alibaba's Logistics Arm Cainiao Files For Hong Kong IPO

Via Benzinga

Topics Artificial Intelligence

Looking Into Sanofi's Recent Short Interest ↗

September 18, 2023

Via Benzinga

(SNY) - Analyzing Sanofi's Short Interest ↗

August 29, 2023

Via Benzinga

Weight Loss Drugs Like Wegovy Could Have Linked Anesthesia Complications, European Medicines Agency To Investigate ↗

September 27, 2023

The European Medicines Agency (EMA) is set to address concerns related to patients taking drugs such as Novo Nordisk A/S's (NYSE

Via Benzinga

Multi-Billion Dollar Treatment Market For Lung Infection That Causes Over 200,000 Hospitalizations Annually With Elderly, Young At Most Risk Has Game-Changing New Entrant ↗

September 26, 2023

Read the latest report on NanoViricides here

Via Benzinga

Dupixent® (dupilumab) sBLA for Treatment of Eosinophilic Esophagitis (EoE) in Children Aged 1 to 11 Accepted for FDA Priority Review

September 26, 2023

From Regeneron Pharmaceuticals, Inc.

Via GlobeNewswire

CDC Backs Pfizer's RSV Infection Maternal Vaccine During Pregnancy As Protection For Infants ↗

September 25, 2023

Friday, The Centers for Disease Control and Prevention recommended the first respiratory syncytial virus (RSV) vaccine for pregnant people to protect their newborns from severe RSV

Via Benzinga

2 Top Biotech Stocks to Buy Right Now ↗

August 14, 2023

These drugmakers are among the most dominant in the world.

Via The Motley Fool

Why Shares of MacroGenics Are Jumping Thursday ↗

August 10, 2023

The company announced second-quarter earnings.

Via The Motley Fool

Dow Tumbles 200 Points; Darden Restaurants Posts Upbeat Profit ↗

September 21, 2023

U.S. stocks traded lower toward the end of trading, with the Dow Jones falling around 200 points on Thursday. The Dow traded down 0.58% to 34,239.48 while the NASDAQ fell 1.20% to 13,307.77. The S&P...

Via Benzinga

Topics Stocks

Why Seelos Therapeutics Shares Are Trading Lower By 31%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

September 21, 2023

Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares climbed 81.5% to $0.2793 after jumping 64% on Wednesday.

Via Benzinga

Gold Down Over 1%; FedEx Shares Rise On Earnings Beat ↗

September 21, 2023

U.S. stocks traded lower midway through trading, with the Dow Jones falling around 150 points on Thursday. The Dow traded down 0.46% to 34,284.15 while the NASDAQ fell 1.05% to 13,327.80. The S&P 500...

Via Benzinga

Topics Stocks

Nasdaq Down Over 1%; US Initial Jobless Claims Fall More Than Expected ↗

September 21, 2023

U.S. stocks traded lower this morning, with the Nasdaq Composite falling over 150 points on Thursday. Following the market opening Thursday, the Dow traded down 0.56% to 34,248.45 while the NASDAQ fell...

Via Benzinga

Topics Stocks

Why Is Kidney-Disease Focused Travere Therapeutics Stock Trading Lower Today? ↗

September 21, 2023

Travere Therapeutics Inc (NASDAQ: TVTX) announced

Via Benzinga

Elon Musk-Backed Neuralink Starts Participant Enrollment For Paralysis, Eli Lilly Cracks Down on Counterfeit Weight Loss Drugs, Meta Looks to Capitalize on India's In-App Payment Surge: Today's Top Stories ↗

September 20, 2023

Benzinga

Via Benzinga

FDA Rejects EpiPen Alternative - ARS Pharmaceuticals' Allergic Reaction Nasal Spray ↗

September 20, 2023

The FDA issued a Complete Response Letter regarding ARS Pharmaceuticals Inc's (NASDAQ: SPRY) New Drug Application (NDA) for neffy (epinephrine nasal spray) in the treatment of Allergic Reactions (Type...

Via Benzinga

3 Stocks to Buy to Ride Europe’s Coming Market Surge ↗

September 19, 2023

With Europe’s markets looking to perform better in the second half of 2023, here are three European stocks to buy to ride the wave.

Via InvestorPlace

Moderna's R&D Day Unveils Strategic Roadmap Beyond COVID Franchise: Goldman Sachs ↗

September 14, 2023

On Wednesday, Moderna Inc (NASDAQ: MRNA) conducted an R&D Day event outlining its strategic initiatives across four key areas - Respiratory Vaccines, Latent/Other Vaccines, Oncology Therapeutics,

Via Benzinga

This Market Could Be Worth $10 Billion by 2030 -- 2 Stocks to Buy Now ↗

September 14, 2023

This market is currently in its infancy.

Via The Motley Fool

'Transformative Event' For First Wave BioPharma: License Agreement for Hopeful Gastrointestinal Candidate From Sanofi ↗

September 14, 2023

First Wave BioPharma Inc (NASDAQ: FWBI) announced an agreement with Sanofi SA (NASDAQ: SNY) to license Capeserod, a selective 5-HT4 receptor partial agonist, which First Wave will repurpose and develop...

Via Benzinga

Flu Vaccine Results Give Moderna (MRNA) Stock a Shot in the Arm ↗

September 13, 2023

Moderna released encouraging results for its late-stage trial of its flu vaccine. Now, MRNA stock is looking like more than a one-trick pony.

Via InvestorPlace

Moderna Stock Has Been Beaten Up; Why The CFO Says Its Story Is 'Misunderstood' ↗

September 13, 2023

Moderna unveiled promising results in flu on Wednesday, adding to its respiratory suite.

Via Investor's Business Daily

Could This Medicine Be the Next Winner for Novartis? ↗

August 23, 2023

The Swiss drugmaker recently reported that a drug candidate met the primary endpoints in phase 3 clinical trials.

Via The Motley Fool

FDA Greenlights Pfizer's RSV Vaccine: Moms Can Now Protect Babies Before Birth ↗

August 22, 2023

Monday, the FDA approved Pfizer Inc's (NYSE: PFE) Abrysvo (Respiratory Syncytial Virus Vaccine), the company's bivalent RSV prefusion F (RSVpreF) vaccine, to prevent the infection in infants from birth...

Via Benzinga

Is Regeneron Pharmaceuticals Still a Top Growth Stock? ↗

August 21, 2023

The biotech's focus on innovation could be a boon for shareholders.

Via The Motley Fool

2 Biotech Stocks That Could Make You Richer ↗

August 18, 2023

Neither is performing particularly well this year compared to the broader market, but don't let that chase you away.

Via The Motley Fool

Amazon's Boon for Diabetes Patients - Streamlining Pharmacy Discounts ↗

August 15, 2023

Amazon.Com Inc's (NASDAQ: AMZN) online pharmacy launched a new initiativ

Via Benzinga

< Previous 1 2

...

15 16 17 18 19 20 21 22 23

...

39 40 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.